Evolution of policy for the treatment of substance use disorders in Qatar

被引:0
|
作者
Majid Alabdulla
Nimesh Samarasinghe
Iain Tulley
Shuja Reagu
机构
[1] Mental Health Services,
[2] Hamad Medical Corporation,undefined
[3] College of Medicine,undefined
[4] Qatar University,undefined
[5] Weill Cornell Medicine,undefined
关键词
Qatar; Middle East North Africa; Substance abuse policy; Mental health;
D O I
暂无
中图分类号
学科分类号
摘要
There is a marked paucity of published evidence on the extent and nature of substance use disorders in the State of Qatar. This is mirrored by a dearth of information on the policy for the treatment of substance use disorders in the public domain. Between 2007 and 2017, substance use disorders have risen from the third to leading cause of disability in Qatar. More recently, Qatar has shifted from applying a punitive only paradigm in managing substance use problems to recognizing the role of treatment and care for people with substance use disorders. Recently published official documents in Qatar define addiction as a disease and as a chronic condition where people with substance use disorders should be treated as patients who need care and assistance. This shifts the onus of providing, and developing services, for individuals with substance use disorders with healthcare providers rather than purely with the criminal justice system. Following cabinet approval, the recently established Permanent Committee for Addiction Treatment headed by the Minister of Public Health, signals the need to institutionalize systems and structures to upscale demand reduction programmes in the country. This article is a descriptive examination of the shifts in substance abuse treatment policy in Qatar, the major factors influencing this evolution, and will utilise some of the policy science theories to describe and analyse policy outcomes. The article will also frame the substance use problem in Qatar for the first time, based on documents published by various government organisations.
引用
收藏
相关论文
共 50 条
  • [1] Evolution of policy for the treatment of substance use disorders in Qatar
    Alabdulla, Majid
    Samarasinghe, Nimesh
    Tulley, Iain
    Reagu, Shuja
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
  • [2] Policy and legislation for the treatment of mental health and substance use disorders in Qatar
    Wadoo, Ovais
    Althani, Shiekha Haya Abdulla Q. F.
    Latoo, Javed
    Alabdulla, Majid
    ASIAN JOURNAL OF PSYCHIATRY, 2023, 79
  • [3] Setting the policy agenda for the treatment of substance use disorders in Iran
    Saeid Mirzaei
    Vahid Yazdi-Feyzabadi
    Mohammad Hossein Mehrolhassani
    Nouzar Nakhaee
    Nadia Oroomiei
    Harm Reduction Journal, 19
  • [4] Setting the policy agenda for the treatment of substance use disorders in Iran
    Mirzaei, Saeid
    Yazdi-Feyzabadi, Vahid
    Mehrolhassani, Mohammad Hossein
    Nakhaee, Nouzar
    Oroomiei, Nadia
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [5] Perceptions of the State Policy Environment and Adoption of Medications in the Treatment of Substance Use Disorders
    Knudsen, Hannah K.
    Abraham, Amanda J.
    PSYCHIATRIC SERVICES, 2012, 63 (01) : 19 - 25
  • [6] Gabapentin for the Treatment of Substance Use Disorders
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2013, 51 (12) : 11 - 14
  • [7] Treatment of Adolescent Substance Use Disorders
    Belendiuk K.A.
    Riggs P.
    Current Treatment Options in Psychiatry, 2014, 1 (2) : 175 - 188
  • [8] PSYCHOPHARMACOLOGICAL TREATMENT OF SUBSTANCE USE DISORDERS
    Yule, Amy
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S124 - S124
  • [9] AGONIST TREATMENT IN SUBSTANCE USE DISORDERS
    Le Strat, Yann
    ADDICTION, 2010, 105 (11) : 2031 - 2031
  • [10] Substance use disorders: Assessment and treatment
    Liskow, BI
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (04): : 665 - 665